Tg Therapeutics

Developer of treatments for B-cell malignancies and autoimmune diseases

placeNew York City, New York, United States calendar_todayFounded 1993 groups264 employees language tgtherapeutics.com

Registered entities

Social engagement

Social engagement: 48.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Private equity150%

Recent activity

9 Jun 2026
Event
Fireside Chat with TG CEO Mike Weiss at the Goldman Sachs 47th Annual Global Healthcare Conference
9 Jun 2026
Event
Goldman Sachs 47th Annual Global Healthcare Conference
3 Jun 2026
Event
Fireside Chat with TG CEO Mike Weiss at the Jefferies Global Healthcare Conference 2026
Coming soon